年別の研究成果
年別の研究成果
検索結果
-
2022
Nevertheless, the importance of coagulation abnormalities should be emphasized in international sepsis guidelines
Iba, T., Nishida, O., Levy, J. H. & Levi, M., 12-2022, In: Journal of Intensive Care. 10, 1, 4.研究成果: Letter › 査読
Open Access -
Recommendations for long-term outcomes in sepsis and septic shock: a comparison between Japanese and international guidelines
Kawai, Y. & Nishida, O., 12-2022, In: Journal of Intensive Care. 10, 1, 6.研究成果: Letter › 査読
Open Access -
2021
Why participation in an international clinical trial platform matters during a pandemic? Launching REMAP-CAP in Japan
Kamata, K., Jindai, K., Ichihara, N., Saito, H., Kato, H., Kunishima, H., Shintani, A., Nishida, O. & Fujitani, S., 12-2021, In: Journal of Intensive Care. 9, 1, 34.研究成果: Letter › 査読
Open Access -
2019
Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
Hasegawa, D. & Nishida, O., 24-06-2019, In: Critical care (London, England). 23, 1, p. 231 1 p.研究成果: Letter › 査読
Open Access3 被引用数 (Scopus) -
2016
Recombinant human thrombomodulin inhibits neutrophil extracellular trap formation in vitro
Shimomura, Y., Suga, M., Kuriyama, N., Nakamura, T., Sakai, T., Kato, Y., Hara, Y., Yamashita, C., Nagasaki, H., Kaneki, M. & Nishida, O., 22-07-2016, In: Journal of Intensive Care. 4, 1, 48.研究成果: Letter › 査読
20 被引用数 (Scopus)